Bayer Q3 2025: Adjusted Profit Jumps as Company Books €934m in Litigation Charges—Guidance Intact, Shares Rise
Published: November 12, 2025 Germany’s Bayer posted a stronger‑than‑expected third quarter on Wednesday, even as it set aside additional money for U.S. glyphosate and PCB cases. The life‑sciences group kept its full‑year profit outlook, pointed to further one‑off burdens this year, and saw its shares climb intraday. Reuters+2n-tv+2 Key takeaways Adjusted profit beats as cost discipline bites Bayer’s third‑quarter performance landed ahead of forecasts thanks to tighter cost control and a steadier Crop Science contribution. Adjusted EBITDA rose 20.8% to €1.51 billion, versus about €1.28 billion expected by analysts, while revenue printed at €9.66 billion. The top line dipped 3% on a reported